Verrica Interim CFO John J. Kirby acquires $24,650 of common shares

Verrica Pharmaceuticals Interim CFO John J. Kirby purchased 5,000 common shares on the open market at a weighted average price of $4.93, totaling $24,650. Following this transaction, Kirby holds direct beneficial ownership of 23,962 common shares.

Verrica Pharmaceuticals Interim CFO John J. Kirby bought 5,000 common shares in an open-market purchase. * The shares were acquired at a weighted average price of $4.93. * Kirby reported direct beneficial ownership of 23,962 common shares following the transaction. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Verrica Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001556327-26-000003), on August 18, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

VRCA